L-Carnitine 1000 Biotech Nutrition , ,
Electron microscopic analysis of FTD and amyotrophic lateral sclerosis patients with TDP43 pathology revealed prominent mitochondrial impairment, including abnormal and/or depleted cristae, concordant with ultrastructural changes observed in both cellular and animal models of TDP43 proteinopathy (Wang et al., 2019)
The Intensifying GLP-1 Race While Novo Nordisk recently secured FDA approval for an oral version of semaglutide becoming the first to market an oral GLP-1RA for obesity Eli Lilly continues to lead in injectable sales with: Zepbound (obesity) Mounjaro (type 2 diabetes) Lilly is also awaiting an FDA decision on its oral candidate, orforglipron
June 08, 2026 8 min read June 08, 2026 5 min read June 08, 2026 5 min read
2023;21:e3002230
We also offer monthly specials so you can check out our highlighted services for the month